Efficacy and Safety of IDegAsp in a Real-World Korean Population with Type 2 Diabetes Mellitus

CONCLUSION: In real-world clinical practice in Korea, the change of insulin regimen to IDegAsp was associated with an improvement in glycemic control without increase of hypoglycemia, supporting the use of IDegAsp for patients with T2DM uncontrolled with basal or premix insulin.PMID:38410023 | DOI:10.4093/dmj.2023.0297
Source: Diabetes and Metabolism Journal - Category: Endocrinology Authors: Source Type: research